Nevirapine (Nev) v zidovudine (Zid) for reducing the risk of mother to child transmission of HIV-1 infection*
| Outcomes | Nev | Zid | RRR (95% CI) | NNT (CI) |
|---|---|---|---|---|
| *Abbreviations defined in glossary; RRR, NNT, and CI calculated from data in article. | ||||
| HIV-1 infection | ||||
| 6–8 weeks | 11.8% | 20% | 39% (12 to 59) | 13 (9 to 43) |
| 18 months | 15.7% | 25.8% | 37% (14 to 55) | 11 (7 to 28) |
| HIV-1 infection or death | ||||
| 18 months | 20.7% | 30.7% | 33% (11 to 49) | 10 (7 to 30) |